Novartis Pharmaceuticals Corporation has announced the launch of a complimentary dental industry-focused Web seminar series entitled "Benefits of Bisphosphonate Therapy vs. Frequency of Oral Complications: An Educational Program for Dental Professionals."

A total of 30, one-hour web seminars are to be conducted between October and December. They will be presented by a rotating roster of clinicians who are leading experts on this compelling and highly relevant subject.

"Benefits of Bisphosphonate Therapy vs. Frequency of Oral Complications: An Educational Program for Dental Professionals" will cover the following topics:

* Overview of bisphosphonates and uses in treatment of osteoporosis and metastatic bone disease
* Osteonecrosis of the jaw (ONJ) background
* ONJ frequency in oncology and osteoporosis patients treated with bisphosphonates
* Review of ONJ studies and management

For more information, visit oral health webinar to obtain a complete Web seminar schedule.

To read more about Novartis Pharmaceuticals, go to Novartis Pharmaceuticals.

To comment on this topic, go to PennWell Dental Community site.